Pulsenmore (PLSM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.87, +3.31% vs the prior close of $1.81.
- Volume 25.34K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PLSM jumps 3.3% to $1.87. Closed at $1.87, +3.31% vs the prior close of $1.81. Day range $1.72β$1.87, opened at $1.75.
PLSM daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β PLSM jumps 3.3% to $1.87
- Closed at $1.87, +3.31% vs the prior close of $1.81. Day range $1.72β$1.87, opened at $1.75.
- Volume was 25.34K shares, 0.4x its 50-day average of 70.47K β lighter than usual.
- Price is -24.6% vs its 50-day average ($2.48).
- 52-week range $1.71β$12.97; today's close sits at 1% of that range, 85.6% below the 52-week high.
Oct 15, 2026 β PLSM dips 0.5% to $1.81, a 6-month low
- Closed at $1.81, -0.55% vs the prior close of $1.82. Day range $1.71β$1.95, opened at $1.88.
- Volume was 32.30K shares, 0.5x its 50-day average of 70.42K β lighter than usual.
- Price is -27.9% vs its 50-day average ($2.51).
- 52-week range $1.71β$12.97; today's close sits at 1% of that range, 86.0% below the 52-week high.
Oct 14, 2026 β PLSM slides 4.2% to $1.82
- Closed at $1.82, -4.21% vs the prior close of $1.90. Day range $1.81β$2.10, opened at $1.89.
- Volume was 40.40K shares, 0.6x its 50-day average of 69.99K β lighter than usual.
- Price is -28.5% vs its 50-day average ($2.55).
- 52-week range $1.75β$12.97; today's close sits at 1% of that range, 86.0% below the 52-week high.
Oct 13, 2026 β PLSM jumps 4.4% to $1.90
- Closed at $1.90, +4.40% vs the prior close of $1.82. Day range $1.83β$1.91, opened at $1.90.
- Volume was 39.10K shares, 0.6x its 50-day average of 69.61K β lighter than usual.
- Price is -26.3% vs its 50-day average ($2.58).
- 52-week range $1.75β$12.97; today's close sits at 1% of that range, 85.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 β PLSM dips 1.6% to $1.82, a 6-month low
- Closed at $1.82, -1.62% vs the prior close of $1.85. Day range $1.75β$1.95, opened at $1.94.
- Volume was 17.70K shares, 0.3x its 50-day average of 69.67K β lighter than usual.
- Price is -30.3% vs its 50-day average ($2.61).
- 52-week range $1.75β$12.97; today's close sits at 1% of that range, 86.0% below the 52-week high.
Oct 9, 2026 β PLSM slides 3.6% to $1.85, a 6-month low
- Closed at $1.85, -3.65% vs the prior close of $1.92. Day range $1.83β$1.91, opened at $1.86.
- Volume was 16.10K shares, 0.2x its 50-day average of 69.54K β lighter than usual.
- Price is -30.2% vs its 50-day average ($2.65).
- 52-week range $1.82β$12.97; today's close sits at 0% of that range, 85.7% below the 52-week high.
Oct 8, 2026 β PLSM rises 0.7% to $1.92
- Closed at $1.92, +0.73% vs the prior close of $1.91. Day range $1.82β$2.00, opened at $1.97.
- Volume was 33.50K shares, 0.5x its 50-day average of 69.70K β lighter than usual.
- Price is -28.4% vs its 50-day average ($2.68).
- 52-week range $1.82β$12.97; today's close sits at 1% of that range, 85.2% below the 52-week high.
Oct 7, 2026 β PLSM slides 11.8% to $1.91, a 6-month low
- Closed at $1.91, -11.76% vs the prior close of $2.16. Day range $1.83β$2.13, opened at $2.10.
- Volume was 74.40K shares, 1.1x its 50-day average of 69.22K.
- Price is -29.7% vs its 50-day average ($2.71).
- 52-week range $1.83β$12.97; today's close sits at 1% of that range, 85.3% below the 52-week high.
Oct 6, 2026 β PLSM dips 2.3% to $2.16, a 6-month low
- Closed at $2.16, -2.26% vs the prior close of $2.21. Day range $2.11β$2.24, opened at $2.19.
- Volume was 37.10K shares, 0.5x its 50-day average of 69.98K β lighter than usual.
- Price is -21.1% vs its 50-day average ($2.74).
- 52-week range $1.97β$12.97; today's close sits at 2% of that range, 83.3% below the 52-week high.
Oct 5, 2026 β PLSM rises 0.9% to $2.21
- Closed at $2.21, +0.91% vs the prior close of $2.19. Day range $2.14β$2.27, opened at $2.16.
- Volume was 29.10K shares, 0.4x its 50-day average of 70.36K β lighter than usual.
- Price is -20.0% vs its 50-day average ($2.76).
- 52-week range $1.97β$12.97; today's close sits at 2% of that range, 83.0% below the 52-week high.
Oct 2, 2026 β PLSM rises 0.7% to $2.19
- Closed at $2.19, +0.69% vs the prior close of $2.17. Day range $2.14β$2.28, opened at $2.21.
- Volume was 24.30K shares, 0.3x its 50-day average of 71.17K β lighter than usual.
- Price is -21.4% vs its 50-day average ($2.79).
- 52-week range $1.97β$12.97; today's close sits at 2% of that range, 83.1% below the 52-week high.
PLSM latest news & SEC filings
Every SEC filing by or about PLSM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Guz-Lavi Racheli converted options/RSUs into 46,874 shares at $0.03 (β$1.50K) on Oct 14, 2026; now holds 46,874
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Oct 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Oct 8, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 8, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 1, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Aug 31, 2026 Β· Form POS AM β POS AM filing
POS AM filing
Aug 31, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 31, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 19, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 6, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 13, 2026 Β· Form 424B3 β Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade PLSM
- How much it moves: over the last 20 sessions the average daily move was 3.40% (largest 11.8%). That is a volatile stock.
- Liquidity: about 45.56K shares (β$85.19K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.87 vs a range of $1.71β$12.97 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 13, 2026; 6-K Sep 17, 2026; 6-K Sep 8, 2026.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
PLSM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.75 | 1.87 | 1.72 | 1.87 | 25.34K |
| Oct 15, 2026 | 1.88 | 1.95 | 1.71 | 1.81 | 32.30K |
| Oct 14, 2026 | 1.89 | 2.10 | 1.81 | 1.82 | 40.40K |
| Oct 13, 2026 | 1.90 | 1.91 | 1.83 | 1.90 | 39.10K |
| Oct 12, 2026 | 1.94 | 1.95 | 1.75 | 1.82 | 17.70K |
| Oct 9, 2026 | 1.86 | 1.91 | 1.83 | 1.85 | 16.10K |
| Oct 8, 2026 | 1.97 | 2.00 | 1.82 | 1.92 | 33.50K |
| Oct 7, 2026 | 2.10 | 2.13 | 1.83 | 1.91 | 74.40K |
| Oct 6, 2026 | 2.19 | 2.24 | 2.11 | 2.16 | 37.10K |
| Oct 5, 2026 | 2.16 | 2.27 | 2.14 | 2.21 | 29.10K |
| Oct 2, 2026 | 2.21 | 2.28 | 2.14 | 2.19 | 24.30K |
| Oct 1, 2026 | 2.27 | 2.48 | 2.14 | 2.17 | 43.00K |
| Sep 30, 2026 | 2.26 | 2.26 | 2.10 | 2.22 | 38.60K |
| Sep 29, 2026 | 2.27 | 2.36 | 1.97 | 2.19 | 53.40K |
| Sep 28, 2026 | 2.40 | 2.55 | 2.23 | 2.28 | 32.20K |
| Sep 25, 2026 | 2.46 | 2.61 | 2.40 | 2.41 | 62.10K |
| Sep 24, 2026 | 2.52 | 2.63 | 2.40 | 2.57 | 101.60K |
| Sep 23, 2026 | 2.40 | 2.64 | 2.35 | 2.44 | 98.00K |
| Sep 22, 2026 | 2.41 | 2.47 | 2.29 | 2.37 | 86.00K |
| Sep 21, 2026 | 2.33 | 2.39 | 2.28 | 2.33 | 26.90K |
About Pulsenmore
Pulsenmore (PLSM) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in ISRAEL. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 2064764.
PLSM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jonathan Adereth | Director | Mar 18, 2026 |
| Racheli Guz-Lavi | Director | Mar 18, 2026 |
| Hagai Itkin | Director | Mar 18, 2026 |
| Anat Loewenstein | Director | Mar 18, 2026 |
| Linda Messalem | Director | Mar 18, 2026 |
| Elazar Sonnenschein | Chief Executive Officer | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Hamelsdorf | GC & Corporate Secretary | Mar 18, 2026 |
| Eran Hirsh | Chief Financial Officer | Mar 18, 2026 |
| Meir Shmouely | VP Software Development | Mar 18, 2026 |
| Elazar Sonnenschein | Chief Executive Officer | Mar 18, 2026 |
| Minelu Sonnenschein | VP R&D | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PLSM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
PLSM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PLSM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.